Ketek Label Change Reflects Evidence of Liver-Damage Risk
Just over a year ago, the FDA warned consumers and health care providers that Ketek' (telithromycin), an antibiotic often used to treat pneumonia and upper respiratory infections, had been implicated in three reported cases of liver toxicity.
This premium content is locked for LawJournalNewsletters subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN LawJournalNewsletters
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already have an account? Sign In Now
For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.